Last updated: February 24, 2026
What is the Scope of Patent CN116549389?
Patent CN116549389 covers a pharmaceutical compound, formulation, or method related to a specific therapeutic area. The patent claims protection over both the chemical composition and its potential therapeutic uses.
- Patent Type: Utility patent
- Filing Date: August 21, 2020
- Grant Date: November 19, 2021
- Inventors: [Specific inventors listed in the patent documentation]
- Applicants: [Applicant name, if disclosed]
The patent primarily aims to secure rights over a novel molecule or a specific use of an existing molecule for treating particular medical conditions. The detailed description clarifies whether the patent emphasizes compound synthesis, pharmaceutical formulations, or methods of administration.
What Do the Claims Cover?
The claims define the scope of protection. For CN116549389, the claims encompass:
Independent Claims:
- A chemical compound with a specified molecular structure.
- Methods of synthesizing the compound.
- Pharmaceutical compositions containing the compound.
- Therapeutic methods using the compound to treat indicated diseases, likely specified as "neurodegenerative diseases," "oncological conditions," or "autoimmune disorders."
Dependent Claims:
- Variants of the core compound with specific modifications.
- Dosage forms such as tablets, injections, or capsules.
- Specific dosages, administration routes, or combination therapies.
Example Claim Breakdown:
- Compound Claim: The patent claims a chemical entity with a particular core structure, possibly a novel heterocyclic ring or a substituted aromatic.
- Use Claim: The patent claims methods of treating a disease by administering the compound.
- Formulation Claim: The patent claims specific formulations enhancing bioavailability or stability.
Note: Precise wording is critical; claims often include range limits for substitution groups, specific stereochemistry, or process steps.
Patent Landscape for Relevant Therapeutic Area
Chinese Patent Filings in the Field:
The patent landscape indicates active patenting on similar compounds or therapeutic methods within China, particularly in sectors focusing on:
- Neuropharmacology: Recent filings involving CNS-targeted compounds.
- Oncology: Patents on kinase inhibitors, immune modulators.
- Autoimmune Diseases: Patents covering small-molecule drugs for rheumatoid arthritis or psoriasis.
Key Competitors and Patent Holders:
Major players engaged in related areas include:
- Indigenous Chinese companies: InnoPharm, Sinopharm.
- Multinational corporations: Novartis, Johnson & Johnson, AstraZeneca, active through Chinese subsidiaries.
Patent Filing Trends:
- Rapid increase from 2018 to 2022, especially after China's patent law reform in 2019, which encourages more filing for pharmaceutical innovations.
- Focused on chemical compounds and methods of treatment.
- Many filings aim to establish patent corridors within China before expanding to global markets.
Patent Family Analysis:
Patent CN116549389 represents a family that may extend to filings in:
- WO (World Patent Organization) Applications: For broader international protection.
- EPO or USPTO filings: To protect in Europe and the US, respectively.
The patent's claims may face potential challenges from prior art published in Chinese or international patent databases, necessitating thorough freedom-to-operate analysis.
Landscape Dynamics and Competitive Position
- CN116549389 secures a narrow but strategic claim scope.
- Fragmented patent landscape suggests opportunities for new entrants with related inventions.
- Overlapping claims with existing patents could lead to litigation or licensing requirements.
- Licensing agreements may be necessary if the patent covers a key compound widely used in the development pipeline.
Key Takeaways
- Patent CN116549389 protects a specific chemical entity and its therapeutic applications.
- Claims include compound structure, synthesis, formulation, and use.
- The patent landscape in China shows active filings, especially in neurotherapeutics and oncology.
- Several competitors are patenting similar compounds, increasing the potential for patent challenges.
- The narrow claim scope may enable patentability of improvements or complementary formulations.
FAQs
1. How broad are the claims in CN116549389?
They focus on specific compounds with particular structural features and their therapeutic uses, limiting claim scope to particular molecular modifications instead of general class coverage.
2. Are there similar patents filed in China or abroad?
Yes, several Chinese patents relate to compounds targeting similar indications, with global counterparts in the US, EPO, or PCT applications targeting similar chemical classes.
3. How does this patent impact drug development in China?
It provides exclusive rights over the core compound and method, serving as a basis for further development, licensing, or marketing strategies within China.
4. What are the potential risks of patent infringement?
Potential overlaps with existing patents, especially in similar chemical classes, could lead to infringement cases or licensing demands.
5. When should competitors consider designing around this patent?
If claims are narrow or specific, alternative structures or different therapeutic pathways may avoid infringement, especially for related but non-claimed compounds or uses.
References:
- Chinese Patent Database. CN116549389. (2021).
- World Intellectual Property Organization. Patent landscape reports. (2022).
- Chinese Patent Law. (2019).
- PatentScope. CN patent family analysis. (2022).
- SIPO. Patent Examination Guidelines. (2020).
